nitroglycerin has been researched along with metformin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bagg, W; Braatvedt, GD; Drury, PL; Gamble, G; Sharpe, N; Whalley, GA | 1 |
| Cornoldi, A; Fini, M; Mercuro, G; Rosano, GM; Vitale, C; Volterrani, M | 1 |
| Teslenko, IuV | 1 |
| Anderson, JJA; Coppin, B; Couper, JJ; Gent, R; Giles, LC; Leggett, CE; Peña, AS | 1 |
| Čapo, I; Lalošević, D; Miljković, D; Popović, DJ; Popović, JK; Popović, KJ | 1 |
| Čapo, I; Lalošević, D; Miljković, D; Popović, DJ; Popović, JK; Popović, KJ; Poša, M | 1 |
| Abbas, HAA; Abdel-Karim, SAM; El-Ganiny, AMA; El-Sayed, MA | 1 |
1 review(s) available for nitroglycerin and metformin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for nitroglycerin and metformin
| Article | Year |
|---|---|
Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes.
Topics: Blood Glucose; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Nitroglycerin; Time Factors; Treatment Outcome; Ultrasonography | 2001 |
Metformin improves endothelial function in patients with metabolic syndrome.
Topics: Brachial Artery; Endothelium, Vascular; Female; Homeostasis; Humans; Hypoglycemic Agents; Image Processing, Computer-Assisted; Insulin Resistance; Male; Metabolic Syndrome; Metformin; Middle Aged; Multivariate Analysis; Nitroglycerin; Ultrasonography; Vasodilator Agents | 2005 |
Effect of Metformin on Vascular Function in Children With Type 1 Diabetes: A 12-Month Randomized Controlled Trial.
Topics: Adolescent; Blood Vessels; Brachial Artery; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Nitroglycerin | 2017 |
5 other study(ies) available for nitroglycerin and metformin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Оptimization of stable angina standard therapy in patients with concomitant osteoarthritis and obesity].
Topics: Adult; Aged; Angina, Stable; Anti-Inflammatory Agents, Non-Steroidal; Body Mass Index; Body Weight; Carbohydrate Metabolism; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Exercise Tolerance; Female; Humans; Lipid Metabolism; Male; Metformin; Middle Aged; Nitroglycerin; Obesity; Osteoarthritis | 2013 |
Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters.
Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Female; Fibrosarcoma; Male; Mesocricetus; Metformin; Nitroglycerin | 2020 |
Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Disulfiram; Female; Fibrosarcoma; Male; Mebendazole; Mesocricetus; Metformin; Neoplasms, Experimental; NF-kappa B; Nitroglycerin; Oxidative Stress; Signal Transduction; Tumor Burden | 2021 |
Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Diclofenac; Domperidone; Humans; Metformin; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nitroglycerin; Staphylococcal Infections; Staphylococcus aureus | 2022 |